Jazz Pharmaceuticals plc — Director's Dealing 2022

Dec 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-12-05

Reporting Person: Carr Patricia (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-05	Ordinary Shares	S	63	$152.0632	Disposed	5934	Direct

Footnotes

F1: 63 ordinary shares were acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2022.